Published yesterday:
[
www.practiceupdate.com]
“These real-world findings suggest that deployment of the AtriClip has been associated with major adverse events, including risk of bleeding, often requiring conversion to open-heart surgery, thromboembolism, and death. These data are limited by event reporting heterogeneity and an inability to assess the total number of procedures performed, thus precluding estimation of adverse event incidence.”
Geez!